Department of Urology, Weill Cornell Medical College, New York, New York.
Center for Reproductive Medicine and Infertility, Weill Cornell Medical College, New York, New York.
J Urol. 2022 Sep;208(3):676-683. doi: 10.1097/JU.0000000000002728. Epub 2022 May 2.
Men who survive cancer as children or young adults may have severe spermatogenic impairment with azoospermia requiring surgical sperm retrieval and assisted reproductive technologies. We assessed treatment outcomes from a large series of cancer patients with prior radiation and/or chemotherapy.
Men with nonobstructive azoospermia who underwent initial microsurgical testicular sperm extraction from 1995-2020 from a high-volume surgeon at a single institution were identified. Those with a history of malignancy treated by radiation therapy and/or chemotherapy were included. The primary outcome was successful sperm retrieval.
A total of 106 men were evaluated, of whom 57 received chemotherapy and radiation, 44 received only chemotherapy and 5 received only radiation. Sperm retrieval was successful in 39 of 106 (37%) men, with higher likelihood of retrieval in men who received only chemotherapy compared to men who received chemotherapy and radiation (61% vs 18%, p <0.001). None of the 18 patients who received chemotherapy with radiation to the pelvis had successful sperm retrieval, compared to 26% of patients who received chemotherapy with extra-pelvic radiation (p=0.02).
Chemotherapy and radiation for cancer may result in nonobstructive azoospermia that can be treated to allow fertility. However, pelvic radiation therapy is associated with the worst prognosis for successful treatment with microsurgical sperm retrieval and fertilization; we observed no cases of successful retrieval in men who received pelvic radiation therapy. These data are useful for pretreatment counseling, suggesting that men with prior radiation therapy may not be candidates for surgical sperm retrieval.
儿童或青年期癌症幸存者可能存在严重的生精功能障碍,导致无精子症,需要手术取精和辅助生殖技术。我们评估了一系列接受过放疗和/或化疗的癌症患者的治疗结果。
从一位高容量外科医生在单一机构从 1995 年至 2020 年进行的初始显微睾丸精子提取中确定了患有非阻塞性无精子症的男性。纳入有接受放疗和/或化疗治疗的恶性肿瘤病史的患者。主要结局是成功的精子提取。
共评估了 106 名男性,其中 57 名接受化疗和放疗,44 名仅接受化疗,5 名仅接受放疗。106 名男性中有 39 名(37%)成功提取了精子,仅接受化疗的男性比接受化疗和放疗的男性更有可能提取精子(61%比 18%,p<0.001)。在接受盆腔化疗加放疗的 18 名患者中,没有成功提取精子,而接受盆腔外化疗的患者中有 26%成功提取精子(p=0.02)。
癌症的化疗和放疗可能导致非阻塞性无精子症,可以通过治疗来实现生育能力。然而,盆腔放疗与显微取精和受精成功治疗的预后最差;我们观察到在接受盆腔放疗的男性中没有成功提取精子的病例。这些数据有助于治疗前咨询,表明先前接受过放疗的男性可能不是手术取精的候选者。